The Senior Scene

People living in certain rural parts of Pierce County, including Key Peninsula and Orting, will soon have more government-funded resources to prepare for wildfires thanks to a $1 million grant from the federal Environmental Protection Agency. 

The EPA awarded the money to Tacoma-Pierce County Health Department for a three-year period to protect against wildfires, wildfire smoke, and the health effects associated with both.

“Climate change is linked to longer, warmer, and drier summers that lead to an increase in wildfires,” said Cindy Haverkamp, a coordinator of the project. “This new problem might be a lasting one. We must do all we can to help prepare our communities.” 

The federal funding will support the community-led Wildfire Preparedness Initiative. Officials said the Health Department will work with Pierce Conservation District and community partners on outreach and education, and develop relationships to form coalitions in what are considered underserved rural areas that include Lakebay, Orting, and Eatonville, among other communities. The areas were chosen because they have more people than other areas in Pierce County who are 65 or older, live alone, are disabled, have lower birthweights and life expectancies at birth, and are at increased risk of cardiovascular disease.

Residents will participate in public dialogues about wildfire issues, finishing with a countywide summit meeting.

The Humane Society for Tacoma and Pierce County has so many dogs in its shelter, it’s begging the public to adopt them. For free, temporarily.

The agency is waiving adoption fees for adult dogs from March 12-17. As of March 11, the shelter in Tacoma was caring for about 120 canines, plus another 39 in foster homes.

“As one of the few open-admission animal shelters in the state, we take in animals no matter their age, breed, or behavioral and medical needs. Just last week, we tended to a dog that had been shot three times and was among 10 rescued in a mere 72 hours, pushing our capacity to the limits,” said Leslie Dalzell, chief executive officer of the local Humane Society. “We are now needing to double or even triple kennel occupancy to provide care for our community’s most vulnerable animals.”

Every adoptable dog has had a wellness exam from shelter staff, been spayed or neutered, received their initial vaccines, and is microchipped with national registration. Their pictures and information are available at www.thehumanesociety.org/adopt. 

Adoption fees, when in effect, can range from $175 to $250. They help pay for services that the dogs receive before being adopted. Spay or neuter surgery alone can cost about $400 at a veterinary hospital, officials said.

Creating space in the shelter through adoptions “enables us to extend our care to countless more animals in dire need,” said Dalzell.

She said another way the public can help lighten the shelter’s load is by helping reunite an apparently lost pet with its owner. They can provide the animal with a temporary home, if possible, and take the following steps:

1. Walk the dog around the area in hope of finding its owner. Most dogs don’t wander far from home, officials said.

2. Have the pet scanned for a microchip at your local veterinary clinic.

3. Post online and put up signs to help locate the owners.

4. Call the shelter to give a description of the pet for it to be included in its found-pet records.

More information is at www.thehumanesociety.org/lost-pets.

The federal government’s new out-of-pocket spending cap for prescription drugs in Medicare Part D promises to be a big money-saver for well over 1 million beneficiaries when it takes effect next year.

The $2,000 cap, part of the Inflation Reduction Act of 2022, will lead to thousands of dollars in savings for Medicare patients who take high-cost drugs for cancer, rheumatoid arthritis, and other serious conditions. It follows the elimination this year of a longstanding requirement that Part D enrollees pay 5 percent of their drug costs out-of-pocket after their drug expenditures reach a certain threshold. 

If the cap been in place in 2021, for example, 1.5 million Medicare beneficiaries would have benefitted because their out-of-pocket costs for prescription drugs exceeded $2,000, according to Kaiser Family Foundation (KFF) after its review of Part D drug claims. About 200,000 beneficiaries spent $5,000 or more for their prescriptions that year, while another 300,000 spent between $3,000 and $5,000. The rest spent between $2,000 and $3,000. 

In six states — New York, Pennsylvania, Ohio, Illinois, North Carolina, and New Jersey — between 50,000 and 82,000 beneficiaries spent more than $2,000 out-of-pocket for prescription drugs in 2021. The numbers were higher in California, Florida, and Texas, where more than 100,000 Part D enrollees exceeded the threshold that year. In Washington, the number was 30,000.

In 2025, Medicare beneficiaries will pay no more than $2,000 out of pocket for drugs covered under Part D, Medicare’s outpatient drug benefit. This is due to a provision in the Inflation Reduction Act  (IRA), which included several changes to the Part D program designed to lower patient out-of-pocket costs and reduce what Medicare spends on prescription drugs. Surveys have shown a large majority of Americans support the Inflation Reduction Act. But he pharmaceutical industry isn’t as enamored with it. In February, representatives of big drug companies—Bristol Myers Squibb, Johnson and Johnson, and Merck–testified at a committee hearing of Congress on the subject of their companies’ opposition to the Medicare controls of drug prices, which currently are as much as four times higher in the U.S. than in other countries. Lawsuits challenging the policy have been part of the industry’s claims that price controls would harm its market-based system and potentially reduce its research and development of new drugs.

One in five U.S. adults report that they sometimes don’t buy a prescription because of the cost, while one in 10 say they’ve cut or skipped doses of medicine in the past year, according to a KFF poll. Higher drug costs also disproportionately impact low-income families, rural Americans, and people with disabilities.

Despite making billions of dollars in profits “on the backs of consumers,” the pharmaceutical companies want “to rip away savings from seniors by banning Medicare from negotiating for lower prices,” said Leslie Dach, chief executive officer of Protect Our Care.

Sources: KFF (Kaiser Family Foundation), a non-profit research organization, and Protect Our Care, a non-profit advocate of lower-cost healthcare.